Explore
Validate
LearnPA5-113520
antibody from Invitrogen Antibodies
Targeting: MAGED2
11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386
Western blot
ELISA
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Immunocytochemistry [1]
- Other assay [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-113520 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- MAGED2 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Recombinant full-length protein
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µg
- Concentration
- 2 mg/mL
- Storage
- -20°C or -80°C if preferred
Submitted references Expression and Prognostic Value of Melanoma-Associated Antigen D2 in Gliomas.
Yan J, Li S, Lenahan C, Chen H, Wen J, Huang Q, Jiang Q, Guo F, Deng T, Mo L
Brain sciences 2022 Jul 26;12(8)
Brain sciences 2022 Jul 26;12(8)
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunocytochemical analysis of MAGED2 in Hela cells using a MAGED2 polyclonal antibody (Product # PA5-113520) at a dilution of 1:145. The cells were treated with 30mM sodium butyrate for 4 hours and counter stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the primary antibody overnight at 4°C. The secondary antibody was an Alexa Fluor 488-congugated Goat Anti-Rabbit IgG(H+L).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunoprecipitation analysis of MAGED2 in HepG2 whole cell lysate using a MAGED2 polyclonal antibody (Product # PA5-113520).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunoprecipitation analysis of MAGED2 in HepG2 whole cell lysate using a MAGED2 polyclonal antibody (Product # PA5-113520).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- The glioma U251-MG cells were transfected with a lipofectamine vector expressing the MAGED2 CRISPR. ( A ) Fluorescence microscopy is used to assess transfection effectiveness 72 h after transfection. qRT-PCR test is used to determine the knockdown effectiveness of MAGED2 ( B ) and Western blotting ( C ). *** p < 0.001 compared with the Scramble CRISPR group; n = 6/group.
